US equities
|
NVDA
$238.53
▲+1.96%
SPCX
$167.23
▲+5.20%
MU
$1,063.80
▼-1.03%
TSLA
$380.35
▲+2.63%
MSFT
$525.61
▲+1.56%
SNDK
$1,709.05
▼-0.64%
INTC
$117.25
▼-1.74%
META
$743.00
▲+2.05%
NVDA
$238.53
▲+1.96%
SPCX
$167.23
▲+5.20%
MU
$1,063.80
▼-1.03%
TSLA
$380.35
▲+2.63%
MSFT
$525.61
▲+1.56%
SNDK
$1,709.05
▼-0.64%
INTC
$117.25
▼-1.74%
META
$743.00
▲+2.05%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by PHIL Inc.
PHIL Partners with Biotechnology Leader, Evolved Health, to Launch New Day™ Skin Spray Direct-to-Patient Program
September 01, 2026
From
PHIL Inc.
Via
Business Wire
PHIL Invests in State-of-the-Art Cash Dispense Capabilities, Expanding Direct-to-Patient Fulfillment for Pharma
April 21, 2026
From
PHIL Inc.
Via
Business Wire
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable
April 02, 2026
From
PHIL Inc.
Via
Business Wire
Phil and RedHill Biopharma Partner to Increase Access to Talicia®
July 06, 2023
From
Phil Inc.
Via
Business Wire
Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management
June 06, 2023
From
Phil Inc.
Via
Business Wire
Tickers
TEVA
Phil, Inc. Forges Strategic Partnership with Syneos Health to Improve Patient Access to Prescriptions
October 25, 2022
From
Phil Inc.
Via
Business Wire